What the panel ordered
Defendant's Petition for Reconsideration of the October 27, 2025 Findings and Award is denied.
Defendant filed a timely Petition for Reconsideration of the October 27, 2025 Findings and Award by the WCJ, which found injury arising out of employment to applicant's left knee and right hip, and industrial hypertension, but deferred finding on heart and internal organs injury. The WCJ had previously issued a stipulated award on October 31, 2022 for 33% permanent disability to left knee and right hip only.
What was disputed, and how it came out
Each issue the panel decided, with the reasoning it gave. An outcome is what this panel did on this record — not a rule, and not a prediction.
The WCJ found new and further disability of the left knee and hypertension based on substantial medical evidence, including unrebutted opinions of PQME Dr. Mahmoudi and Dr. Sclafani, and concluded the stipulated award was properly reopened under section 5410 and 5803.
From the decision · page 12Internal medicine PQME Dr. Mahmoudi also provides a substantial opinion regarding the worsening of applicant's hypertension. As noted in the WCJ's Report, Dr. Mahmoudi opined that applicant has industrial hypertension due to deconditioning and the cumulative effects of his injury. (See Applicant's Exhibit 4, Deposition of Dr. Mahmoudi, p. 8, lines 3-12). He felt that applicant had an increase in hypertension from stage 1 to stage 2 and that increase is industrial, especially given applicant's use of NSAIDs. (Id. at p. 9, lines 17-25). He confirmed that all the prior blood pressure measurements that he is using to find causations for the hypertension predate the stipulated award of October 31, 2022. (Id. at p. 16, lines 21-25). He also testified that applicant's first class 2 diagnosis for hypertension was on April 14, 2021. (Id. at p. 35, lines 6-16). The QME reaffirmed that he felt this was industrial due to the NSAIDs, weight gain, and total knee replacement, especially since NSAIDs can increase blood pressure. (Id. at pp.